Novartis Investigative Site

Haarlem 2035 RC

0 studies enrolling now · 3 studies all time

What they study most

Acute Heart Failure, Atherosclerosis, Chronic Heart Failure

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed